United States · FDA National Drug Code directory
Fabrazyme
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 58468-0040_9b786f81-f4d8-4bc6-8f5f-68adbbfb60d1
- Product NDC
- 58468-0040
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Composition / generic term
- AGALSIDASE BETA
- Labeler
- Genzyme Corporation
- Marketing category
- BLA
- Marketing start / end (source format)
- 20081217
- Source listing expiry
- 20261231
Source-listed ingredients
- AGALSIDASE BETA — 5 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, GLASS in 1 CARTON (58468-0040-1) / 7 mL in 1 VIAL, GLASS · 58468-0040-1
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →